[go: up one dir, main page]

AR009133A1 - Un procedimiento para preparar 5,6-dimetil-2-(4-fluorofenilamino)-4-(1-metil- 1,2,3,4-tetrahidroisoquinolin-2-il)pirimidina, procedimientos para preparar una 4-halogeno-2-(4-fluorofenilamino)-5,6-dimetilpirimidina y un derivado de pirimidina util como intermediario - Google Patents

Un procedimiento para preparar 5,6-dimetil-2-(4-fluorofenilamino)-4-(1-metil- 1,2,3,4-tetrahidroisoquinolin-2-il)pirimidina, procedimientos para preparar una 4-halogeno-2-(4-fluorofenilamino)-5,6-dimetilpirimidina y un derivado de pirimidina util como intermediario

Info

Publication number
AR009133A1
AR009133A1 ARP970104978A ARP970104978A AR009133A1 AR 009133 A1 AR009133 A1 AR 009133A1 AR P970104978 A ARP970104978 A AR P970104978A AR P970104978 A ARP970104978 A AR P970104978A AR 009133 A1 AR009133 A1 AR 009133A1
Authority
AR
Argentina
Prior art keywords
pirimidine
dimethyl
fluorophenylamine
preparing
methyl
Prior art date
Application number
ARP970104978A
Other languages
English (en)
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019960049380A external-priority patent/KR0185292B1/ko
Priority claimed from KR1019960049381A external-priority patent/KR100193080B1/ko
Priority claimed from KR1019960049382A external-priority patent/KR100209587B1/ko
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of AR009133A1 publication Critical patent/AR009133A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Un procedimiento para la preparacion de 5,6-dimetil-2-(4-fluofenilamino)- 4-(1-metil-1,2,3,4-tetrahidroisoquinolín-2-il)pirimidina representada por laformula (I) que se presenta a continuacion y sus sales de adicion ácidas; en segundo lugar, au n procedimiento para la preparacion de un intermediario conel fin de preparar el compuesto (I) y, en tercer lugar, a un compuesto intermediario novedoso. Más específicamente, en primer lugar, a unprocedimiento para la preparacion de 5,6-dime til-2- (4-fluofenilamino)-4-(1-metil-1,2,3,4-tetrahidroisoquinolin-2-il) pirimidina representada por laformula (I) que se presenta a continuacion y sus sales de adicion ácidas, al hacer reaccionar un derivado de pirimidina representado por lasiguienteformula (II-A), donde Hal representa un halogeno, con 1-metil-1,2,3,4- tetrahidroisoquinolina representada por la siguiente formula (III), en segundolugar, a un procedimiento para la preparacion del derivado de pirimidina de la for mula(III) y en tercer lugar, a un compuesto intermediario novedoso queincluye el derivado de piriminina de la formula (II-A)
ARP970104978A 1996-10-29 1997-10-28 Un procedimiento para preparar 5,6-dimetil-2-(4-fluorofenilamino)-4-(1-metil- 1,2,3,4-tetrahidroisoquinolin-2-il)pirimidina, procedimientos para preparar una 4-halogeno-2-(4-fluorofenilamino)-5,6-dimetilpirimidina y un derivado de pirimidina util como intermediario AR009133A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1019960049380A KR0185292B1 (ko) 1996-10-29 1996-10-29 (s)-피리미딘 유도체의 제조방법
KR1019960049381A KR100193080B1 (ko) 1996-10-29 1996-10-29 (r)-피리미딘 유도체의 제조방법
KR1019960049382A KR100209587B1 (ko) 1996-10-29 1996-10-29 피리미딘 유도체의 제조방법

Publications (1)

Publication Number Publication Date
AR009133A1 true AR009133A1 (es) 2000-03-08

Family

ID=27349413

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104978A AR009133A1 (es) 1996-10-29 1997-10-28 Un procedimiento para preparar 5,6-dimetil-2-(4-fluorofenilamino)-4-(1-metil- 1,2,3,4-tetrahidroisoquinolin-2-il)pirimidina, procedimientos para preparar una 4-halogeno-2-(4-fluorofenilamino)-5,6-dimetilpirimidina y un derivado de pirimidina util como intermediario

Country Status (5)

Country Link
AR (1) AR009133A1 (es)
BR (1) BR9712392A (es)
HU (1) HU226752B1 (es)
TR (1) TR199900943T2 (es)
WO (1) WO1998018784A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100272471B1 (ko) * 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
GB0110338D0 (en) * 2001-04-27 2001-06-20 Sb Pharmco Inc Novel processes
WO2004012659A2 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
US7776873B2 (en) * 2005-12-01 2010-08-17 Yuhan Corporation Method for treating damage to gastric mucosa
EP2007362B1 (en) 2006-04-04 2018-09-05 KG Acquisition LLC Oral dosage forms including an antiplatelet agent and an acid inhibitor
CN102993173B (zh) * 2012-12-28 2014-09-03 山东大学 洛氟普啶的制备方法
CN105601611A (zh) * 2014-11-19 2016-05-25 江苏天士力帝益药业有限公司 一种盐酸洛氟普啶多晶型物及其制备方法
CN105669642B (zh) * 2014-11-19 2020-06-09 江苏天士力帝益药业有限公司 一种盐酸洛氟普啶的制备方法
CN107759562B (zh) * 2016-08-21 2020-10-23 常州四药制药有限公司 一种盐酸洛氟普啶的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182584A (en) * 1966-03-31 1970-02-25 Ici Ltd Pyrimidine derivates and the use thereof as fungicides
ES2081863T3 (es) * 1989-03-22 1996-03-16 Ciba Geigy Ag Plaguicidas.
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
AU688087B2 (en) * 1994-08-13 1998-03-05 Yuhan Corporation Novel pyrimidine derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
HUP9903520A1 (hu) 2000-05-28
HU226752B1 (en) 2009-09-28
HUP9903520A3 (en) 2002-01-28
TR199900943T2 (xx) 1999-12-21
BR9712392A (pt) 2000-01-25
WO1998018784A1 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
AR009133A1 (es) Un procedimiento para preparar 5,6-dimetil-2-(4-fluorofenilamino)-4-(1-metil- 1,2,3,4-tetrahidroisoquinolin-2-il)pirimidina, procedimientos para preparar una 4-halogeno-2-(4-fluorofenilamino)-5,6-dimetilpirimidina y un derivado de pirimidina util como intermediario
FI903331A0 (fi) Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
AR245710A1 (es) Procedimiento de preparacion de derivados de benzopirano.
ES8705400A1 (es) Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina.
DK506587A (da) Imidderivater
FI902555A0 (fi) Diarylstyrylkinolindisyror.
ES8604529A1 (es) Un procedimiento para la preparacion de 1-(4 pirimidiniloxi)-3(heterilalquilamino)-2-propanoles.
ES2165052T3 (es) Procedimiento para la preparacion de derivados de pirimidina.
ES8604886A1 (es) Un procedimiento para la preparacion de derivados de pirazol
ES528496A0 (es) Procedimiento para la obtencion de acidos 1-ciclopropil-6-fluor-1,4-dihidro-4-oxo-7-(4-(oxoalquil)-1-piperazinil)-3-quinolincarboxilico y sus derivados
RO92792B (ro) Procedeu pentru prepararea unor derivati de pirazol
KR870007127A (ko) 퀴놀론 카복실산 유도체의 제조방법
ES8706122A1 (es) Un procedimiento para la preparacion de agentes inotropicos de quinolona
KR870003078A (ko) N-설파밀-3-(2-구아니디노-티아졸-4-일-메틸티오)프로피온아미딘의 제조방법
FI822133A0 (fi) Nya 1-benzyl-3,4-dihydro-isokinolinderivat
ES8507120A1 (es) Procedimiento para la preparacion de derivados de acido 5-fenilcarbamoilbarbiturico
GB1017264A (en) Quinazolinone derivatives and the manufacture thereof
ES2066534T3 (es) Procedimiento para la oxidacion de derivados de hidroximetilpiridina en derivados de acido piridincarboxilico.
NO903488L (no) Nye forbindelser.
GB560345A (en) Manufacture of sulphanilamido-polyalkylpyrimidines
IL65666A (en) Derivatives of 4-aminomethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones and process for their preparation
ES8800192A1 (es) Procedimiento para la obtencion del acido 5-cloro-6-(3-clorobencenosulfonil)-1,3-benzodioxol-2-carboxilico.
ES511873A0 (es) Procedimiento para la preparacion de 4-(4-fenil-1-piperidinil) metil-5-acil-1,3-dihidro-2h-imidazol-2-onas.
ES8504715A1 (es) Derivados de benzo (f) quinolina
KR880013923A (ko) N-(2-피리미딜)피페라지닐 유도체의 제조방법

Legal Events

Date Code Title Description
FG Grant, registration